Friday, April 28, 2017

BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package

* Says U.S. wholesale acquisition cost of Rydapt for AML

indication is $7,495 for 14-day package and $14,990 for 28-day

package - spokeswoman

Further company coverage:

Read more

No comments:

Post a Comment